1
Westgeest, Hans, Kuppen, Malou, Van den Eertwegh, AJM, de Wit, Ronald, Coenen, J, van den Berg, HP, Mehra, N, van Oort, IM, Fossion, L, Hendriks, MP, Bloemendal, HJ, van de Luijtgaarden, ACM, Huinink, DT, van den Bergh, ACM, Bosch, JG, Polee, MB, Weijl, N, Bergman, AM, Uyl - de Groot, Carin, Gerritsen, WR
Veröffentlicht in: Westgeest , H , Kuppen , M , Van den Eertwegh , AJM , de Wit , R , Coenen , J , van den Berg , HP , Mehra , N , van Oort , IM , Fossion , L , Hendriks , MP , Bloemendal , HJ , van de Luijtgaarden , ACM , Huinink , DT , van den Bergh , ACM , Bosch , JG , Polee , MB , Weijl , N , Bergman , AM , Uyl - de Groot , C & Gerritsen , WR 2019 , ' Second-Line Cabazitaxel Treatment in Castration-Resistant Prostate Cancer Clinical Trials Compared to Standard of Care in CAPRI: Observational Study in the Netherlands ' , Clinical Genitourinary Cancer , vol. 17 , no. 5 , pp. E946-E956 . https://doi.org/10.1016/j.clgc.2019.05.018;
2019
Veröffentlicht in: Westgeest , H , Kuppen , M , Van den Eertwegh , AJM , de Wit , R , Coenen , J , van den Berg , HP , Mehra , N , van Oort , IM , Fossion , L , Hendriks , MP , Bloemendal , HJ , van de Luijtgaarden , ACM , Huinink , DT , van den Bergh , ACM , Bosch , JG , Polee , MB , Weijl , N , Bergman , AM , Uyl - de Groot , C & Gerritsen , WR 2019 , ' Second-Line Cabazitaxel Treatment in Castration-Resistant Prostate Cancer Clinical Trials Compared to Standard of Care in CAPRI: Observational Study in the Netherlands ' , Clinical Genitourinary Cancer , vol. 17 , no. 5 , pp. E946-E956 . https://doi.org/10.1016/j.clgc.2019.05.018;
2019
2
Kwakman, JJM, Vink, G, Vestjens, JH, Beerepoot, LV, de Groot, JW, Jansen, RL, Opdam, FL, Boot, H, Creemers, GJ, van Rooijen, JM, Los, M, Vulink, AJE, Schut, H, van Meerten, Esther, Baars, A, Hamberg, P, Kapiteijn, E, Sommeijer, DW, Punt, CJA, Koopman, M
Veröffentlicht in: Kwakman , JJM , Vink , G , Vestjens , JH , Beerepoot , LV , de Groot , JW , Jansen , RL , Opdam , FL , Boot , H , Creemers , GJ , van Rooijen , JM , Los , M , Vulink , AJE , Schut , H , van Meerten , E , Baars , A , Hamberg , P , Kapiteijn , E , Sommeijer , DW , Punt , CJA & Koopman , M 2018 , ' Feasibility and effectiveness of trifluridine/tipiracil in metastatic colorectal cancer: real-life data from The Netherlands ' , International Journal of Clinical Oncology , vol. 23 , no. 3 , pp. 482-489 . https://doi.org/10.1007/s10147-017-1220-0;
2018
Veröffentlicht in: Kwakman , JJM , Vink , G , Vestjens , JH , Beerepoot , LV , de Groot , JW , Jansen , RL , Opdam , FL , Boot , H , Creemers , GJ , van Rooijen , JM , Los , M , Vulink , AJE , Schut , H , van Meerten , E , Baars , A , Hamberg , P , Kapiteijn , E , Sommeijer , DW , Punt , CJA & Koopman , M 2018 , ' Feasibility and effectiveness of trifluridine/tipiracil in metastatic colorectal cancer: real-life data from The Netherlands ' , International Journal of Clinical Oncology , vol. 23 , no. 3 , pp. 482-489 . https://doi.org/10.1007/s10147-017-1220-0;
2018
3
Jochems, A, van der Kooij, MK, Fiocco, M, Schouwenburg, MG, Aarts, MJB, Akkooi, ACJ, van den Berkmortel, F, Blank, CU, Van den Eertwegh, AJM, Franken, Margreet, de Groot, JB, Haanen, J, Hospers, GA, Koornstra, RH, Kruit, Wim, Louwman, M, Piersma, D, van Rijn, RS, Suijkerbuijk, KPM, ten Tije, AJ, Vreugdenhil, G, Wouters, M, van Zeijl, MCT, van der Hoeven, KJM, Kapiteijn, E
Veröffentlicht in: Jochems , A , van der Kooij , MK , Fiocco , M , Schouwenburg , MG , Aarts , MJB , Akkooi , ACJ , van den Berkmortel , F , Blank , CU , Van den Eertwegh , AJM , Franken , M , de Groot , JB , Haanen , J , Hospers , GA , Koornstra , RH , Kruit , W , Louwman , M , Piersma , D , van Rijn , RS , Suijkerbuijk , KPM , ten Tije , AJ , Vreugdenhil , G , Wouters , M , van Zeijl , MCT , van der Hoeven , KJM & Kapiteijn , E 2019 , ' Metastatic Uveal Melanoma: Treatment Strategies and Survival-Results from the Dutch Melanoma Treatment Registry ' , Cancers , vol. 11 , no. 7 , 1007 . https://doi.org/10.3390/cancers11071007;
2019
Veröffentlicht in: Jochems , A , van der Kooij , MK , Fiocco , M , Schouwenburg , MG , Aarts , MJB , Akkooi , ACJ , van den Berkmortel , F , Blank , CU , Van den Eertwegh , AJM , Franken , M , de Groot , JB , Haanen , J , Hospers , GA , Koornstra , RH , Kruit , W , Louwman , M , Piersma , D , van Rijn , RS , Suijkerbuijk , KPM , ten Tije , AJ , Vreugdenhil , G , Wouters , M , van Zeijl , MCT , van der Hoeven , KJM & Kapiteijn , E 2019 , ' Metastatic Uveal Melanoma: Treatment Strategies and Survival-Results from the Dutch Melanoma Treatment Registry ' , Cancers , vol. 11 , no. 7 , 1007 . https://doi.org/10.3390/cancers11071007;
2019
4
Franken, Margreet, Leeneman, Brenda, Jochems, A, Schouwenburg, MG, Aarts, MJB, Akkooi, ACJ, van den Berkmortel, F, Van den Eertwegh, AJM, de Groot, JWB, van der Hoeven, JJM, Hospers, GAP, Kapiteijn, E, Koornstra, RH, Kruit, Wim, Louwman, MW, Piersma, D, van Rijn, RS, Suijkerbuijk, KPM, ten Tije, AJ, Vreugdenhil, G, Wouters, MWJM, Zeijl, M, Haanen, JBAG, Uyl - de Groot, Carin
Veröffentlicht in: Franken , M , Leeneman , B , Jochems , A , Schouwenburg , MG , Aarts , MJB , Akkooi , ACJ , van den Berkmortel , F , Van den Eertwegh , AJM , de Groot , JWB , van der Hoeven , JJM , Hospers , GAP , Kapiteijn , E , Koornstra , RH , Kruit , W , Louwman , MW , Piersma , D , van Rijn , RS , Suijkerbuijk , KPM , ten Tije , AJ , Vreugdenhil , G , Wouters , MWJM , Zeijl , M , Haanen , JBAG & Uyl - de Groot , C 2018 , ' Real-world healthcare costs of ipilimumab in patients with advanced cutaneous melanoma in The Netherlands ' , Anti-Cancer Drugs , vol. 29 , no. 6 , pp. 579-588 . https://doi.org/10.1097/CAD.0000000000000628;
2018
Veröffentlicht in: Franken , M , Leeneman , B , Jochems , A , Schouwenburg , MG , Aarts , MJB , Akkooi , ACJ , van den Berkmortel , F , Van den Eertwegh , AJM , de Groot , JWB , van der Hoeven , JJM , Hospers , GAP , Kapiteijn , E , Koornstra , RH , Kruit , W , Louwman , MW , Piersma , D , van Rijn , RS , Suijkerbuijk , KPM , ten Tije , AJ , Vreugdenhil , G , Wouters , MWJM , Zeijl , M , Haanen , JBAG & Uyl - de Groot , C 2018 , ' Real-world healthcare costs of ipilimumab in patients with advanced cutaneous melanoma in The Netherlands ' , Anti-Cancer Drugs , vol. 29 , no. 6 , pp. 579-588 . https://doi.org/10.1097/CAD.0000000000000628;
2018
5
Jochems, A, Leeneman, Brenda, Franken, Margreet, Schouwenburg, MG, Aarts, MJB, Akkooi, Alexander, van den Berkmortel, F, Van den Eertwegh, AJM, Groenewegen, G, de Groot, JWB, Haanen, JBAG, Hospers, GAP, Kapiteijn, E, Koornstra, RH, Kruit, Wim, Louwman, MW, Piersma, D, van Rijn, RS, ten Tije, AJ, Vreugdenhil, G, Wouters, MWJM, Uyl - de Groot, Carin, van der Hoeven, JJM
Veröffentlicht in: Jochems , A , Leeneman , B , Franken , M , Schouwenburg , MG , Aarts , MJB , Akkooi , A , van den Berkmortel , F , Van den Eertwegh , AJM , Groenewegen , G , de Groot , JWB , Haanen , JBAG , Hospers , GAP , Kapiteijn , E , Koornstra , RH , Kruit , W , Louwman , MW , Piersma , D , van Rijn , RS , ten Tije , AJ , Vreugdenhil , G , Wouters , MWJM , Uyl - de Groot , C & van der Hoeven , JJM 2018 , ' Real-world use, safety, and survival of ipilimumab in metastatic cutaneous melanoma in The Netherlands ' , Anti-Cancer Drugs , vol. 29 , no. 6 , pp. 572-578 . https://doi.org/10.1097/CAD.0000000000000629;
2018
Veröffentlicht in: Jochems , A , Leeneman , B , Franken , M , Schouwenburg , MG , Aarts , MJB , Akkooi , A , van den Berkmortel , F , Van den Eertwegh , AJM , Groenewegen , G , de Groot , JWB , Haanen , JBAG , Hospers , GAP , Kapiteijn , E , Koornstra , RH , Kruit , W , Louwman , MW , Piersma , D , van Rijn , RS , ten Tije , AJ , Vreugdenhil , G , Wouters , MWJM , Uyl - de Groot , C & van der Hoeven , JJM 2018 , ' Real-world use, safety, and survival of ipilimumab in metastatic cutaneous melanoma in The Netherlands ' , Anti-Cancer Drugs , vol. 29 , no. 6 , pp. 572-578 . https://doi.org/10.1097/CAD.0000000000000629;
2018
6
Beije, Nick, Kraan, Jaco, Taal, Walter, van der Holt, Ronnie, Oosterkamp, HM, Walenkamp, AM, Beerepoot, L, Hanse, M, van Linde, ME, Otten, A, Vernhout, René, de Vos, FYF, Gratama, Jan willem, Sleijfer, Stefan, van den Bent, Martin
Veröffentlicht in: Beije , N , Kraan , J , Taal , W , van der Holt , R , Oosterkamp , HM , Walenkamp , AM , Beerepoot , L , Hanse , M , van Linde , ME , Otten , A , Vernhout , R , de Vos , FYF , Gratama , J W , Sleijfer , S & van den Bent , M 2015 , ' Prognostic value and kinetics of circulating endothelial cells in patients with recurrent glioblastoma randomised to bevacizumab plus lomustine, bevacizumab single agent or lomustine single agent. A report from the Dutch Neuro-Oncology Group BELOB trial ' , British Journal of Cancer , vol. 113 , no. 2 , pp. 226-231 . https://doi.org/10.1038/bjc.2015.191;
2015
Veröffentlicht in: Beije , N , Kraan , J , Taal , W , van der Holt , R , Oosterkamp , HM , Walenkamp , AM , Beerepoot , L , Hanse , M , van Linde , ME , Otten , A , Vernhout , R , de Vos , FYF , Gratama , J W , Sleijfer , S & van den Bent , M 2015 , ' Prognostic value and kinetics of circulating endothelial cells in patients with recurrent glioblastoma randomised to bevacizumab plus lomustine, bevacizumab single agent or lomustine single agent. A report from the Dutch Neuro-Oncology Group BELOB trial ' , British Journal of Cancer , vol. 113 , no. 2 , pp. 226-231 . https://doi.org/10.1038/bjc.2015.191;
2015
7
Franken, Margreet, Kanters, Tim, Coenen, JL, De Jong, P, Koene, HR, Lugtenburg, Elly, Jager, Agnes, Uyl - de Groot, Carin
Veröffentlicht in: Franken , M , Kanters , T , Coenen , JL , De Jong , P , Koene , HR , Lugtenburg , E , Jager , A & Uyl - de Groot , C 2018 , ' Potential cost savings owing to the route of administration of oncology drugs: a microcosting study of intravenous and subcutaneous administration of trastuzumab and rituximab in the Netherlands ' , Anti-Cancer Drugs , vol. 29 , no. 8 , pp. 791-801 . https://doi.org/10.1097/CAD.0000000000000648;
2018
Veröffentlicht in: Franken , M , Kanters , T , Coenen , JL , De Jong , P , Koene , HR , Lugtenburg , E , Jager , A & Uyl - de Groot , C 2018 , ' Potential cost savings owing to the route of administration of oncology drugs: a microcosting study of intravenous and subcutaneous administration of trastuzumab and rituximab in the Netherlands ' , Anti-Cancer Drugs , vol. 29 , no. 8 , pp. 791-801 . https://doi.org/10.1097/CAD.0000000000000648;
2018
8
Putora, PM, Bedenne, L, Budach, W, Eisterer, W, van der Gaast, Ate, Jager, R, van Lanschot, Jan, Mariette, C, Schnider, A, Stahl, M, Ruhstaller, T
Veröffentlicht in: Putora , PM , Bedenne , L , Budach , W , Eisterer , W , van der Gaast , A , Jager , R , van Lanschot , J , Mariette , C , Schnider , A , Stahl , M & Ruhstaller , T 2015 , ' Oesophageal cancer: exploring controversies overview of experts' opinions of Austria, Germany, France, Netherlands and Switzerland ' , Radiation Oncology , vol. 10 , no. 116 . https://doi.org/10.1186/s13014-015-0418-4;
2015
Veröffentlicht in: Putora , PM , Bedenne , L , Budach , W , Eisterer , W , van der Gaast , A , Jager , R , van Lanschot , J , Mariette , C , Schnider , A , Stahl , M & Ruhstaller , T 2015 , ' Oesophageal cancer: exploring controversies overview of experts' opinions of Austria, Germany, France, Netherlands and Switzerland ' , Radiation Oncology , vol. 10 , no. 116 . https://doi.org/10.1186/s13014-015-0418-4;
2015